Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer
I would act as if this will become public soon, because ethically and practically that is the safest assumption. The core principle: patient safety first, evidence preserved, regulators informed promptly, and no misleading statements to investors or physicians.Read the full answer